Division of General Internal Medicine, Mayo Clinic, Jacksonville, FL, USA.
Division of Clinical Trials and Biostatistics, Mayo Clinic, Jacksonville, FL, USA.
J Investig Med. 2023 Dec;71(8):896-906. doi: 10.1177/10815589231190560. Epub 2023 Aug 12.
Identifying risk factors for post-acute sequelae of COVID-19 (PASC) is important. We conducted a multicenter cross-sectional survey study to define and characterize risk factors for severe COVID-19 in adults (≥18 years) treated at our virtual COVID-19 clinic from March 1, 2020, through March 31, 2021. We assessed patient demographics, symptom types, and persistence, incidence of PASC, and COVID-19-caused hospitalizations. Surveyed patients were also asked to rate their perception of the severity of their acute COVID-19 symptoms. Continuous variables were summarized descriptively. Differences among groups categorized by acute COVID-19 symptom severity level (mild/very mild, moderate, and severe/very severe) were evaluated with the Kruskal-Wallis rank sum test for continuous measures and the Pearson χ test for categorical measures. A total of 3094 adults completed the survey. More respondents with severe/very severe acute COVID-19 symptoms reported having PASC than did those with mild/very mild and moderate acute symptoms. A significantly greater proportion of respondents with PASC were women (68.4% vs 56.7%, p < 0.001), had been hospitalized (12.2% vs 4.4%, p < 0.001), reported having negative psychological COVID-19-related repercussions (39.9% vs 15.3%, p < 0.001), and required more than 1 month to resume normal activities (38.8% vs 12.9%, p < 0.001) than did those without PASC. These findings may improve our understanding of PASC and provide a framework for early recognition of and intervention for patients at higher risk for PASC. Further research is needed to understand the predictors of persistent symptoms after acute SARS-CoV-2 infection and the risk of PASC.
确定 COVID-19 后急性后遗症(PASC)的风险因素很重要。我们进行了一项多中心横断面调查研究,以定义和描述 2020 年 3 月 1 日至 2021 年 3 月 31 日在我们的虚拟 COVID-19 诊所接受治疗的成年人(≥18 岁)中严重 COVID-19 的风险因素。我们评估了患者的人口统计学特征、症状类型和持续时间、PASC 的发生率以及 COVID-19 导致的住院治疗情况。接受调查的患者还被要求评估他们对急性 COVID-19 症状严重程度的感知。连续变量采用描述性总结。使用 Kruskal-Wallis 秩和检验对连续变量和 Pearson χ 检验对分类变量进行评估,以比较按急性 COVID-19 症状严重程度(轻度/非常轻度、中度和重度/非常重度)分组的组间差异。共有 3094 名成年人完成了调查。报告有严重/非常严重急性 COVID-19 症状的患者中,有 PASC 的比例高于有轻度/非常轻度和中度急性症状的患者。有 PASC 的患者中,女性比例明显更高(68.4%比 56.7%,p<0.001),住院率更高(12.2%比 4.4%,p<0.001),报告有负面的 COVID-19 相关心理影响(39.9%比 15.3%,p<0.001),需要超过 1 个月才能恢复正常活动(38.8%比 12.9%,p<0.001)。这些发现可能有助于我们更好地了解 PASC,并为识别和干预 PASC 风险较高的患者提供框架。需要进一步研究以了解急性 SARS-CoV-2 感染后持续症状的预测因素和 PASC 的风险。